Literature DB >> 18480976

Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather than hyperinsulinemia.

Tatiana C L Koch1, Karlis Briviba, Bernhard Watzl, Achim Bub, Stephan W Barth.   

Abstract

BACKGROUND: Obesity and energy restriction modulate the development of precancerous aberrant crypt foci (ACF) in animal models of colon cancer. AIM: Investigation of the major obesity-associated determinants for ACF-development and underlying mechanisms leading to ACF-modulation, such as changes in DNA damage or colonocytes hyperproliferation.
METHODS: Lean and obese Zucker rats fed ad libitum (a.l.) or obese pair fed (p.f.) were induced with 1,2-dimethylhydrazine (DMH) for colon cancer. Multiple regression analyses were performed to identify major metabolic factors correlated with ACF number and size (aberrant crypts/ACF). DNA damage is analyzed by the comet-assay, epithelial proliferation by immunohistochemistry.
RESULTS: Aberrant crypt foci number was significantly elevated in Zucker obese a.l. (205.7+/-65.4 vs. lean 9.5+/-6.3, P<0.05) and is reduced by pair feeding in Zucker obese rats (81.4+/-28.5 vs. obese a.l., P<0.05). Compared to lean the ACF size was higher in Zucker obese a.l. (2.1+/-0.3 vs. lean 1.3+/-0.2., P<0.05) but is not reduced by pair feeding (1.7+/-0.2; P>0.05). While ACF number and size were modulated by genotype and/or pair feeding the DMH-induced DNA damage and hyperproliferation in colonocytes did not differ significantly between groups. Regression analysis showed that plasma parameters associated with lipid-metabolism (triglycerides, cholesterol, malondialdehyde) significantly correlated with the ACF number and size while parameters linked to carbohydrate-metabolism (glucose, insulin) were weaker determinants.
CONCLUSION: Obesity or pair feeding-associated modulation of ACF correlate with parameters related to lipid-metabolism but is not accompanied by changes in DNA damage and proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480976     DOI: 10.1007/s00394-008-0711-1

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  48 in total

Review 1.  The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease.

Authors:  Konstantinos Karmiris; Ioannis E Koutroubakis; Elias A Kouroumalis
Journal:  Inflamm Bowel Dis       Date:  2005-09       Impact factor: 5.325

Review 2.  Modifiable risk factors for colon cancer.

Authors:  Edward Giovannucci
Journal:  Gastroenterol Clin North Am       Date:  2002-12       Impact factor: 3.806

3.  The effect of exercise on plasma somatomedin-C/insulinlike growth factor I concentrations.

Authors:  A T Smith; D R Clemmons; L E Underwood; V Ben-Ezra; R McMurray
Journal:  Metabolism       Date:  1987-06       Impact factor: 8.694

Review 4.  Nutritional regulation of the insulin-like growth factors.

Authors:  J P Thissen; J M Ketelslegers; L E Underwood
Journal:  Endocr Rev       Date:  1994-02       Impact factor: 19.871

5.  Induction of cytochrome P450IIE1 in the obese overfed rat.

Authors:  J L Raucy; J M Lasker; J C Kraner; D E Salazar; C S Lieber; G B Corcoran
Journal:  Mol Pharmacol       Date:  1991-03       Impact factor: 4.436

6.  Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor.

Authors:  B A Ruggeri; D M Klurfeld; D Kritchevsky; R W Furlanetto
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

7.  Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.

Authors:  S E Dunn; F W Kari; J French; J R Leininger; G Travlos; R Wilson; J C Barrett
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

8.  Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ.

Authors:  K Yamada; S Araki; M Tamura; I Sakai; Y Takahashi; H Kashihara; S Kono
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

9.  Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa.

Authors:  Thomas Aparicio; Sandra Guilmeau; Hélène Goiot; Annick Tsocas; Jean-Pierre Laigneau; André Bado; Iradj Sobhani; Thérèse Lehy
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

10.  Modification of early dimethylhydrazine carcinogenesis by colonic mucosal hyperplasia.

Authors:  S W Barthold; D Beck
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

View more
  4 in total

Review 1.  The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?

Authors:  Frank A Simmen; Rosalia C M Simmen
Journal:  Eur J Cancer Prev       Date:  2011-11       Impact factor: 2.497

2.  Janice Drew's work on diet and cancer.

Authors:  Janice Drew
Journal:  World J Gastrointest Pathophysiol       Date:  2011-08-15

Review 3.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

4.  Diet-induced obesity promotes colon tumor development in azoxymethane-treated mice.

Authors:  Iina Tuominen; Leina Al-Rabadi; Dimitris Stavrakis; Iordanis Karagiannides; Charalabos Pothoulakis; James M Bugni
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.